Concepedia

Author

Susan Hoare

The Honourable Society of Lincoln's Inn

Also Known As

S A Hoare, S Hoare, S. A. Hoare, S. Hoare, S.A. Hoare, Susan A. Hoare, Susan Hoare

35

Publications

7.4K

Citations

19

H-Index

44

Concepts

All Affiliations

The Honourable Society of Lincoln's InnMolecular Oncology (United States)Guy's HospitalCancer Research UKQueen Mary University of London
SH

About

Susan Hoare is an author at The Honourable Society of Lincoln's Inn specializing in medicine, endocrinology, and molecular biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

12

14

5.6K

2

Natural Sciences

5

5

2.7K

3

Cell Biology

5

5

3K

4

Biochemistry

3

3

301

5

Biology

1

1

1.4K

Susan Hoare

×

24

Publications

7.3K

Citations

18

H-Index

YearCitations

A signature motif in transcriptional co-activators mediates binding to nuclear receptors

David M. Heery, Eric Kalkhoven, Susan Hoare,

Nature

1997

2.1K

Environmentally persistent alkylphenolic compounds are estrogenic.

R White, Susan Jobling, Susan Hoare,

Endocrinology

1994

1.4K

Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor.

Vincent Cavaillès, Sophie Dauvois, F. L’Horset,

The EMBO Journal

1995

758

Estrogen Receptors α and β Form Heterodimers on DNA

Shaun M. Cowley, Susan Hoare, Sietse Mosselman,

Journal of Biological Chemistry

1997

684

Inhibition of estrogen receptor-DNA binding by the "pure" antiestrogen ICI 164,384 appears to be mediated by impaired receptor dimerization.

Stephen E. Fawell, R White, Susan Hoare,

Proceedings of the National Academy of Sciences

1990

402

A consensus DNA-binding site for the androgen receptor.

Peter J. Roche, Susan Hoare, Marti G. Parker

Molecular Endocrinology

1992

267

Tumor Necrosis Factor α As a New Target for Renal Cell Carcinoma: Two Sequential Phase II Trials of Infliximab at Standard and High Dose

Michelle Harrison, Eva Obermueller, Nick Maisey,

Journal of Clinical Oncology

2007

247

Identification of residues in the estrogen receptor that confer differential sensitivity to estrogen and hydroxytamoxifen.

Paul S. Danielian, R White, Susan Hoare,

Molecular Endocrinology

1993

215

A Phase II Study of Etanercept (Enbrel), a Tumor Necrosis Factor α Inhibitor in Patients with Metastatic Breast Cancer

Srinivasan Madhusudan, Martin D. Foster, S. Muthuramalingam,

Clinical Cancer Research

2004

203

A clinical study assessing the tolerability and biological effects of infliximab, a TNF-α inhibitor, in patients with advanced cancer

Ewan Brown, Kellie A. Charles, Susan Hoare,

Annals of Oncology

2008

180

Page 1